{
    "2020-03-05": [
        [
            {
                "time": "",
                "original_text": "健帆生物：拟投资建设血液净化项目 完善公司华南、华中、华北产业战略布局",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "血液净化",
                        "投资项目",
                        "产业布局"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "健帆生物：拟在珠海投资约15亿元建医疗器械（血液净化）项目",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "珠海",
                        "医疗器械",
                        "血液净化",
                        "投资项目"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【健帆生物】【安信医药马帅团队】年报详尽点评：19年业绩符合预期，血液净化业务不断拓展",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "年报",
                        "业绩",
                        "血液净化",
                        "业务拓展"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}